PHARMACOKINETICS OF DOXORUBICIN

被引：2
|
作者：
ERTTMANN, R [1 ]
GRANDT, M [1 ]
ERB, N [1 ]
GARBRECHT, M [1 ]
LANDBECK, G [1 ]
机构：
[1] UNIV HAMBURG,MED KLIN,HAMATOL & ONKOL ABT,D-2000 HAMBURG 13,FED REP GER
来源：
KLINISCHE PADIATRIE | 1986年 / 198卷 / 03期
关键词：
D O I：
10.1055/s-2008-1026889
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：271 / 276
页数：6
相关论文
共 50 条
  • [31] Pharmacokinetics of docetaxel, doxorubicin, and cyclophosphamide in combination treatment
    Cirillo, I
    Reyno, L
    Gelmon, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1189 - 1189
  • [32] Effect of infusion regime on doxorubicin pharmacokinetics in the cat
    Hahn, KA
    Frazier, DL
    Cox, SK
    Legendre, AM
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 1997, 33 (05) : 427 - 433
  • [33] DOXORUBICIN PHARMACOKINETICS - THE EFFECTS OF PROTEIN-DEPRIVATION
    KAPELANSKI, DP
    DALY, JM
    COPELAND, EM
    DUDRICK, SJ
    JOURNAL OF SURGICAL RESEARCH, 1981, 30 (04) : 331 - 337
  • [34] THE INFLUENCE OF RANITIDINE ON THE PHARMACOKINETICS AND TOXICITY OF DOXORUBICIN IN RABBITS
    HARRIS, NL
    BRENNER, DE
    ANTHONY, LB
    COLLINS, JC
    HALTER, S
    HANDE, KR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (04) : 323 - 328
  • [35] EFFECT OF PHENYTOIN ON DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CLINICAL RESEARCH, 1988, 36 (03): : A362 - A362
  • [36] Doxorubicin/taxane combinations: Cardiac toxicity and pharmacokinetics
    Sparano, JA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 14 - 19
  • [37] PHARMACOKINETICS OF DOXORUBICIN IN MAN - DOSE AND SCHEDULE DEPENDENCE
    ERTTMANN, R
    ERB, N
    STEINHOFF, A
    LANDBECK, G
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (05) : 509 - 513
  • [38] EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) : 294 - 298
  • [39] DOXORUBICIN PHARMACOKINETICS IN OBESE CANCER-PATIENTS
    RODVOLD, KA
    RUSHING, DA
    TEWKSBURY, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 247 - 247
  • [40] CYCLOPHOSPHAMIDE (CYC) AND DOXORUBICIN (DOX) PHARMACOKINETICS IN PATIENTS WITH SARCOMAS - EVIDENCE FOR ALTERED DOXORUBICIN METABOLISM
    RIGGS, CE
    EGORIN, MJ
    WHITACRE, M
    AKMAN, SR
    ANGELOU, JE
    VANECHO, DA
    AISNER, J
    BACHUR, NR
    CLINICAL RESEARCH, 1982, 30 (02): : A423 - A423
12345